Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$4,268,308
-$29,187 QoQ
Shares Held
11,787
-3.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#915
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chicago Capital, LLC holds $139,654,335 across 9 Drug Manufacturers - General names. AMGN ranks #4 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
87,354 | $104,775,016 | |
| 2 | JNJ |
Johnson & Johnson
|
56,172 | $14,266,002 | |
| 3 | ABBV |
AbbVie Inc.
|
40,087 | $10,087,492 | |
| 4 | AMGN |
Amgen Inc
This page
|
11,787 | $4,268,308 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,111 | $3,483,763 | |
| 6 | PFE |
Pfizer Inc
|
48,093 | $1,158,079 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,250 | $648,225 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,332 | $547,304 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,268,308 | 11,787 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $4,297,495 | 12,214 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,943,103 | 12,047 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,395,712 | 12,033 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,603,205 | 12,905 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,102,490 | 13,168 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $3,748,003 | 14,380 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $4,628,224 | 14,364 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $5,733,769 | 18,351 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $5,378,765 | 18,918 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $5,360,052 | 18,610 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $3,279,678 | 12,203 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,709,310 | 12,203 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $2,950,075 | 12,203 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,234,674 | 12,316 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,776,026 | 12,316 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,995,266 | 12,311 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $2,916,591 | 12,061 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $2,578,381 | 11,461 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,437,181 | 11,461 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,866,743 | 11,761 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $3,070,564 | 12,341 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $2,837,442 | 12,341 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,128,963 | 12,311 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,903,672 | 12,311 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,018,988 | 9,959 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||